InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.8987
+0.0562 (6.66%)
Sep 4, 2026, 11:46 AM EDT - Market open
InspireMD Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 15.15 | 8.94 | 18.92 | 9.64 | 4.63 | 12 |
Short-Term Investments | 15.27 | 45.27 | 15.72 | 29.38 | 13.17 | 22.04 |
Cash & Short-Term Investments | 30.42 | 54.21 | 34.64 | 39.02 | 17.8 | 34.04 |
Cash Growth | 57.02% | 56.51% | -11.24% | 119.19% | -47.70% | 169.20% |
Accounts Receivable | 1.82 | 2.17 | 1.57 | 1.8 | 1.03 | 1.22 |
Other Receivables | 0.59 | 0.4 | 0.68 | 0.65 | 0.21 | 0.17 |
Receivables | 2.41 | 2.57 | 2.25 | 2.45 | 1.25 | 1.39 |
Inventory | 2.7 | 3.4 | 2.57 | 2.11 | 1.62 | 1.14 |
Prepaid Expenses | 1.1 | 1.3 | 1.06 | 0.58 | 0.66 | 0.52 |
Total Current Assets | 36.63 | 61.47 | 40.52 | 44.16 | 21.33 | 37.09 |
Property, Plant & Equipment | 6.29 | 6.34 | 4.73 | 2.53 | 2.47 | 1.71 |
Other Long-Term Assets | 1.73 | 1.59 | 1.56 | 0.95 | 0.86 | 0.91 |
Total Assets | 44.64 | 69.4 | 46.81 | 47.64 | 24.65 | 39.71 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.65 | 1.26 | 1.25 | 0.94 | 0.66 | 0.89 |
Accrued Expenses | 6.05 | 8.06 | 5.63 | 4.33 | 3.86 | 2.88 |
Current Portion of Leases | 1.06 | 1.07 | 0.54 | 0.56 | 0.42 | 0.42 |
Other Current Liabilities | 0.89 | 0.34 | 0.26 | 0.19 | 0.13 | 0.16 |
Total Current Liabilities | 9.65 | 10.71 | 7.68 | 6.02 | 5.07 | 4.35 |
Long-Term Leases | 1.97 | 2.22 | 1.8 | 1.04 | 1.2 | 0.78 |
Pension & Post-Retirement Benefits | 1.52 | 1.27 | 1.25 | 1.08 | 1 | 1.05 |
Total Liabilities | 13.13 | 14.2 | 10.72 | 8.14 | 7.26 | 6.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 361.81 | 357.49 | 289.59 | 261 | 218.98 | 216.63 |
Retained Earnings | -330.31 | -302.29 | -253.51 | -221.5 | -201.59 | -183.09 |
Total Common Equity | 31.51 | 55.2 | 36.09 | 39.5 | 17.39 | 33.53 |
Shareholders' Equity | 31.51 | 55.2 | 36.09 | 39.5 | 17.39 | 33.53 |
Total Liabilities & Equity | 44.64 | 69.4 | 46.81 | 47.64 | 24.65 | 39.71 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.03 | 3.29 | 2.34 | 1.6 | 1.61 | 1.2 |
Net Cash (Debt) | 27.4 | 50.92 | 32.3 | 37.43 | 16.19 | 32.84 |
Net Cash Growth | 71.76% | 57.66% | -13.70% | 131.19% | -50.70% | 192.01% |
Net Cash Per Share | 0.34 | 0.79 | 0.77 | 1.54 | 2.06 | 4.47 |
Filing Date Shares Outstanding | 46.49 | 46.8 | 29.69 | 23.46 | 8.33 | 8.32 |
Total Common Shares Outstanding | 46.92 | 43.53 | 26.61 | 21.84 | 8.33 | 8.3 |
Working Capital | 26.98 | 50.76 | 32.84 | 38.14 | 16.26 | 32.75 |
Book Value Per Share | 0.67 | 1.27 | 1.36 | 1.81 | 2.09 | 4.04 |
Tangible Book Value | 31.51 | 55.2 | 36.09 | 39.5 | 17.39 | 33.53 |
Tangible Book Value Per Share | 0.67 | 1.27 | 1.36 | 1.81 | 2.09 | 4.04 |
Machinery | - | 5.22 | 3.83 | 2.38 | 2.33 | 2.12 |
Leasehold Improvements | - | 1.09 | 0.86 | 0.72 | 0.49 | 0.24 |